Patents by Inventor Dan Denney

Dan Denney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9605320
    Abstract: Predictive biomarkers identify those patients suffering from immunoglobulin positive (Ig+) B lineage malignancies that are responsive to active immunotherapy, where the active immunotherapy comprises vaccination with a tumor-specific idiotype-immunogen. It is shown herein that patient responsiveness to the idiotype-immunogen is dependent upon the sequence of the immunogen, where an immunogen having a low number of tyrosine residues in the CDR1 (herein termed CDR1-Y10) regions of one or both of the immunogen heavy and light chains is predictive of a positive anti-tumor response, while a high number of CDR1 tyrosine residues (herein termed CDR1-Yhi) is predictive of a low anti tumor response.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: March 28, 2017
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Arash Ash Alizadeh, Dan Denney, Ronald Levy
  • Publication number: 20140220562
    Abstract: Predictive biomarkers identify those patients suffering from immunoglobulin positive (Ig+) B lineage malignancies that are responsive to active immunotherapy, where the active immunotherapy comprises vaccination with a tumor-specific idiotype-immunogen. It is shown herein that patient responsiveness to the idiotype-immunogen is dependent upon the sequence of the immunogen, where an immunogen having a low number of tyrosine residues in the CDR1 (herein termed CDR1-Y10) regions of one or both of the immunogen heavy and light chains is predictive of a positive anti-tumor response, while a high number of CDR1 tyrosine residues (herein termed CDR1-Yhi) is predictive of a low anti tumor response.
    Type: Application
    Filed: January 10, 2012
    Publication date: August 7, 2014
    Inventors: Arash Ash Alizadeh, Dan Denney, Ronald Levy
  • Patent number: 7658258
    Abstract: The present invention features an all terrain, four-wheeled vehicle frame for carrying at least two passengers in a side-by-side riding configuration, comprising a rigid, tubular frame body which provides for a forward passenger compartment having structural support members for carrying a pair of seats for the side-by-side passengers and a rearward engine compartment configured for receiving an engine, power train, and transmission for driving wheels of the vehicle. The vehicle frame also includes a vertical, load-bearing truss member extending generally along a longitudinal, central axis of the vehicle within the passenger compartment, the truss member forming a load-bearing structural member between the pair of seats.
    Type: Grant
    Filed: June 12, 2006
    Date of Patent: February 9, 2010
    Assignee: Thorpe North & Western LLP
    Inventor: Dan Denney
  • Publication number: 20070134249
    Abstract: The present invention provides combination immunotherapy for Non-Hodgkin's Lymphoma. In one embodiment, the combination immunotherapy first provides for the administration of a monoclonal antibody directed to a non-idotypic portion of a lymphoma cell surface immunoglobulin (e.g. a framework region of a variable region). The combination immunotherapy next provides for the administration of an immunogenic composition comprising at least a portion of the same lymphoma cell surface immunoglobulin, whether an idiotypic portion or non-idiotypic portion.
    Type: Application
    Filed: December 8, 2005
    Publication date: June 14, 2007
    Applicants: Genitope Corporation
    Inventors: Dan Denney, Keri Tate, Thomas Theriault
  • Publication number: 20070134248
    Abstract: The present invention provides combination immunotherapy for Non-Hodgkin's Lymphoma. In one embodiment, the combination immunotherapy first provides for the administration of a monoclonal antibody directed to a non-idotypic portion of a lymphoma cell surface immunoglobulin (e.g. a framework region of a variable region). The combination immunotherapy next provides for the administration of an immunogenic composition comprising at least a portion of the same lymphoma cell surface immunoglobulin, whether an idiotypic portion or non-idiotypic portion.
    Type: Application
    Filed: December 8, 2005
    Publication date: June 14, 2007
    Applicant: Genitope Corporation
    Inventors: Dan Denney, Keri Marie Tate, Thomas P. Theriault
  • Publication number: 20070000715
    Abstract: The present invention features an all terrain, four-wheeled vehicle frame for carrying at least two passengers in a side-by-side riding configuration, comprising a rigid, tubular frame body which provides for a forward passenger compartment having structural support members for carrying a pair of seats for the side-by-side passengers and a rearward engine compartment configured for receiving an engine, power train, and transmission for driving wheels of the vehicle. The vehicle frame also includes a vertical, load-bearing truss member extending generally along a longitudinal, central axis of the vehicle within the passenger compartment, the truss member forming a load-bearing structural member between the pair of seats.
    Type: Application
    Filed: June 12, 2006
    Publication date: January 4, 2007
    Inventor: Dan Denney